Their pipelines, however, are more complementary, with AstraZeneca stronger in solid tumors and Bristol Myers in blood cancers and cell therapies.
—
Elsa Ohlen,
CNBC,
6 Aug. 2026
Elsewhere in the world, the approach to diagnosis is so different that very often low-grade tumors aren’t found to begin with — let alone diagnosed as cancer.
Now researchers are investigating whether certain cancers, such as breast cancer, could be added to that list.
—
Lori Youmshajekian,
Scientific American,
8 June 2026
Over time, follow-on R&D added over 40 indications across numerous cancers — including early-stage applications that allow treatment to begin before cancer worsens.
Examples are automatically compiled from online sources to
show current usage.Read More
Opinions expressed in the examples do not represent those of Merriam-Webster or its editors.
Send us feedback.